Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women

BMC Endocrine Disorders

Ingrid Dahlman¹  Peter Arner¹  Anne Bouloumié²  Elisabeth Dungner¹  Pauline Decaunes²  Silvia Lorente-Cebrián¹ 

[1] Department of Medicine Huddinge, Lipid Laboratory, Novum, Karolinska Institutet, Karolinska University Hospital, SE-141 86 Huddinge, Stockholm, Sweden;Institut National de la Santé et de la Recherche Médicale (INSERM), U1048, Institut des maladies cardiovasculaires et métaboliques, Université Toulouse III Paul-Sabatier, Toulouse, France

关键词: Adipose tissue;    Obesity;    Adipokines;    AIF-1;   

Others  :  1085494
DOI  :  10.1186/1472-6823-13-54

 received in 2013-03-12, accepted in 2013-08-20,  发布年份 2013

【 摘 要 】

Background

Allograft inflammatory factor 1 (AIF-1) is a putative obesity gene. Our aim was to examine the expression of AIF-1 in human white adipose tissue (WAT) in relation to obesity and metabolic phenotypes in women.

Methods

WAT secretion of AIF-1 was determined in subcutaneous adipose tissue pieces in vitro by ELISA from 5 subjects. mRNA expression of AIF-1 was determined by RT-qPCR in the isolated cell fractions of adipose tissue (n = 5-6 per group), in subcutaneous and visceral WAT pieces from non-obese (n = 12) and obese women (n = 23), and in some subcutaneous WAT also before and after weight reduction (n = 10). Finally, adipose AIF-1 mRNA was related to metabolic phenotypes in 96 subjects with a wide range of BMI.

Results

AIF-1 was secreted in a time dependent fashion from WAT. The major source of AIF-1 was WAT resident macrophages. Expression of AIF-1 was similar in visceral and subcutaneous WAT and was two-fold increased in obese women (P < 0.01). AIF-1 mRNA expression levels were normalized after weight reduction (P < 0.01). Expression of AIF-1 was inversely correlated with insulin sensitivity as assessed by insulin tolerance test (KITT), and circulating levels of adiponectin (P = 0.02), and positively correlated with insulin resistance as estimated by HOMA (=0.0042).

Conclusions

AIF-1 is a novel adipokine produced mainly by macrophages within human WAT. Its expression is increased in obese women and associates with unfavourable metabolic phenotypes. AIF-1 may play a paracrine role in the regulation of WAT function through cross-talk between macrophages and other cell types within the adipose tissue.

【 授权许可】

   
2013 Lorente-Cebrián et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, et al.: Dynamics of fat cell turnover in humans. Nature 2008, 453(7196):783-787.
• [2]Large V, Arner P: Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 1998, 24(5):409-418.
• [3]Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95(5):2409-2415.
• [4]Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112(12):1785-1788.
• [5]Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92(3):347-355.
• [6]Decaunes P, Esteve D, Zakaroff-Girard A, Sengenes C, Galitzky J, Bouloumie A: Adipose-derived stromal cells: cytokine expression and immune cell contaminants. Methods Mol Biol 2011, 702:151-161.
• [7]Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808.
• [8]Arner P: Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005, 19(4):471-482.
• [9]Dahlman I, Elsen M, Tennagels N, Korn M, Brockmann B, Sell H, Eckel J, Arner P: Functional annotation of the human fat cell secretome. Arch Physiol Biochem 2012, 118(3):84-91.
• [10]Trayhurn P, Drevon CA, Eckel J: Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem 2011, 117(2):47-56.
• [11]Deininger MH, Meyermann R, Schluesener HJ: The allograft inflammatory factor-1 family of proteins. FEBS Lett 2002, 514(2–3):115-121.
• [12]Watano K, Iwabuchi K, Fujii S, Ishimori N, Mitsuhashi S, Ato M, Kitabatake A, Onoe K: Allograft inflammatory factor-1 augments production of interleukin-6, -10 and −12 by a mouse macrophage line. Immunology 2001, 104(3):307-316.
• [13]Autieri MV, Kelemen SE, Wendt KW: AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ Res 2003, 92(10):1107-1114.
• [14]Brauner A, Hertting O, Alkstrand E, Sandberg E, Chromek M, Chen ZW, Ostenson CG: CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1. Perit Dial Int 2003, 23(1):5-13.
• [15]Koshiba H, Kitawaki J, Teramoto M, Kitaoka Y, Ishihara H, Obayashi H, Ohta M, Hara H, Adachi T, Honjo H: Expression of allograft inflammatory factor-1 in human eutopic endometrium and endometriosis: possible association with progression of endometriosis. J Clin Endocrinol Metab 2005, 90(1):529-537.
• [16]Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A, Styrkarsdottir U, Gretarsdottir S, Thorlacius S, Jonsdottir I, et al.: Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009, 41(1):18-24.
• [17]Casimiro I: Role of allograft inflammatory factor-1 (Aif-1) in macrophage activity, atherosclerosis, and obesity. New York: Yeshiva University; 2010.
• [18]Lofgren P, Andersson I, Adolfsson B, Leijonhufvud BM, Hertel K, Hoffstedt J, Arner P: Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state. J Clin Endocrinol Metab 2005, 90(11):6207-6213.
• [19]Bolinder J, Lithell H, Skarfors E, Arner P: Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men. Diabetes 1986, 35(3):282-290.
• [20]Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23(1):57-63.
• [21]Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Lofgren P, Ryden M, Thorne A, Wiren M, Palmer M, et al.: Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 2010, 53(12):2496-2503.
• [22]Klimcakova E, Roussel B, Kovacova Z, Kovacikova M, Siklova-Vitkova M, Combes M, Hejnova J, Decaunes P, Maoret JJ, Vedral T, et al.: Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 2011, 54(4):876-887.
• [23]Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A: From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53(5):1285-1292.
• [24]Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A: Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110(3):349-355.
• [25]Lorente-Cebrian S, Eriksson A, Dunlop T, Mejhert N, Dahlman I, Astrom G, Sjolin E, Wahlen K, Carlberg C, Laurencikiene J, et al.: Differential effects of 1alpha,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr 2011, 51(3):335-342.
• [26]Lonnqvist F, Nordfors L, Jansson M, Thorne A, Schalling M, Arner P: Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest 1997, 99(10):2398-2404.
• [27]Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AS, Wahlen K, Andersson J, Nordstrom EA, Blomqvist L, Sjogren A, et al.: A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Clin Endocrinol Metab 2005, 90(10):5834-5840.
• [28]Arner E, Mejhert N, Kulyte A, Balwierz PJ, Pachkov M, Cormont M, Lorente-Cebrian S, Ehrlund A, Laurencikiene J, Heden P, et al.: Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 2012, 61(8):1986-1993.
• [29]Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, et al.: Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011, 60(7):1917-1925.
• [30]Rosenow A, Arrey TN, Bouwman FG, Noben JP, Wabitsch M, Mariman EC, Karas M, Renes J: Identification of novel human adipocyte secreted proteins by using SGBS cells. J Proteome Res 2010, 9(10):5389-5401.
• [31]Autieri MV, Carbone C, Mu A: Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arteriosclerosis, thrombosis, and vascular biology 2000, 20(7):1737-1744.
• [32]Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation 2003, 112(12):1821-1830.
• [33]Fukui M, Tanaka M, Toda H, Asano M, Yamazaki M, Hasegawa G, Imai S, Fujinami A, Ohta M, Nakamura N: The serum concentration of allograft inflammatory factor-1 is correlated with metabolic parameters in healthy subjects. Metabolism 2012, 61(7):1021-1025.
• [34]Fukui M, Tanaka M, Asano M, Yamazaki M, Hasegawa G, Imai S, Fujinami A, Ohta M, Obayashi H, Nakamura N: Serum allograft inflammatory factor-1 is a novel marker for diabetic nephropathy. Diabetes research and clinical practice 2012, 97(1):146-150.
• [35]Chen X, Kelemen SE, Autieri MV: AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol 2004, 24(7):1217-1222.
• [36]Tian Y, Jain S, Kelemen SE, Autieri MV: AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis. Am J Physiol Cell Physiol 2009, 296(2):C256-266.